Work

International, Multicenter Randomized Preclinical Trials in Translational Stroke Research: It's Time to Act

Year: 2012
Type: editorial
Abstract: Translational stroke research is in a crisis, and pharmaceutical companies continue to exit the field. Many reasons for the apparently insurmountable barrier between the bench and bedside in stroke drug development have been identified. It is time to act now to bridge the gap between preclinical and clinical studies of purported new therapies. We strongly believe that it is too early to abandon translational stroke research.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2037412522
Cites: 11
Cited by: 113
Related to: 10